GMAB Competitors & Alternatives
Compare Genmab AS with similar stocks in the same industry
Biotechnology
GMAB
Main Stock$43.79
Tradestie Score
41
Market Cap
$19.56B
P/E Ratio
31.3
Revenue Growth
0.2%
Analyst Upside
+2.8%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$377.63
|
$36.81B | 69.1 | 38 | Compare |
|
INSM
Insmed, Inc.
|
$93.39
|
$31.13B | - | 53 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$88.12
|
$24.57B | - | 53 | Compare |
|
INCY
Incyte Genomics Inc
|
$115.71
|
$16.93B | 14.9 | 69 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$63.86
|
$15.70B | 33.9 | 49 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.47
|
$15.22B | - | 52 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$243.37
|
$12.36B | 18.3 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$64.53
|
$11.09B | 20.6 | 29 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.49
|
$10.76B | - | 57 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$200.10
|
$10.74B | - | 41 | Compare |
More GMAB Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry